Acelyrin shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Acelyrin (SLRN) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Acelyrin
Tip: Access up to 7 years of quarterly data
All positions including Acelyrin held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Acelyrin by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $1.9M | 618k | 3.14 |
| 2024-09-30 | $4.2M | 851k | 4.93 |
| 2024-06-30 | $12M | 2.6M | 4.41 |
| 2024-03-31 | $18M | 2.6M | 6.75 |
| 2023-12-31 | $24M | 3.2M | 7.46 |
| 2023-09-30 | $32M | 3.2M | 10.17 |
| 2023-06-30 | $77M | 3.7M | 20.90 |